Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode
作者： Joseph Peuskens , Leonard Kaufman , Betty Van Vleymen
DOI: 10.1016/J.SCHRES.2007.05.035
关键词:
摘要: Resolution was defined as achieving the severity component of remission criteria (simultaneous ratings mild or less on 8 PANSS items evaluating core symptoms schizophrenia). Analysis a 6-week open label study with olanzapine 5-20 mg in 306 patients acute exacerbation, shows resolution to be clinically meaningful measure and an achievable outcome for treatment psychosis.
core.ac.uk
elsevier.com
sci-hub.se 参考文章(21)
Jeffrey Lieberman, Darlene Jody, Stephen Geisler, Jose Alvir, Antony Loebel, Sally Szymanski, Margaret Woerner, Michael Borenstein, Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia Archives of General Psychiatry. ,vol. 50, pp. 369- 376 ,(1993) , 10.1001/ARCHPSYC.1993.01820170047006
Robert A. Lasser, Cynthia A. Bossie, Georges M. Gharabawi, John M. Kane, Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection. Schizophrenia Research. ,vol. 77, pp. 215- 227 ,(2005) , 10.1016/J.SCHRES.2005.03.006
G. P. Amminger, F. Resch, R. Mutschlechner, M. H. Friedrich, E. Ernst, Premorbid adjustment and remission of positive symptoms in first-episode psychosis European Child & Adolescent Psychiatry. ,vol. 6, pp. 212- 218 ,(1997) , 10.1007/BF00539928
Cheng-Fang Yen, Cheng-Sheng Chen, Ming-Li Yeh, Ju-Yu Yen, Jhy-Hong Ker, Shang-Ju Yang, Comparison of insight in patients with schizophrenia and bipolar disorder in remission. Journal of Nervous and Mental Disease. ,vol. 190, pp. 847- 849 ,(2002) , 10.1097/00005053-200212000-00008
S. Leucht, R. Lasser, The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry. ,vol. 39, pp. 161- 170 ,(2006) , 10.1055/S-2006-949513
G SETHURAMAN, C TAYLOR, M ENERSON, E DUNAYEVICH, A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia Schizophrenia Research. ,vol. 79, pp. 337- 340 ,(2005) , 10.1016/J.SCHRES.2005.06.015
Rosemary Farmer, Anand Pandurangi, Fred Laine, Brain changes and psychosocial adaptation in schizophrenia Schizophrenia Research. ,vol. 15, pp. 215- ,(1995) , 10.1016/0920-9964(95)95659-W
Clayton E. Curtis, Monica E. Calkins, William M. Grove, Kathleen J. Feil, William G. Iacono, Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives. American Journal of Psychiatry. ,vol. 158, pp. 100- 106 ,(2001) , 10.1176/APPI.AJP.158.1.100
J. Os, T. Burns, R. Cavallaro, S. Leucht, J. Peuskens, L. Helldin, M. Bernardo, C. Arango, W. Fleischhacker, B. Lachaux, J. M. Kane, Standardized remission criteria in schizophrenia Acta Psychiatrica Scandinavica. ,vol. 113, pp. 91- 95 ,(2006) , 10.1111/J.1600-0447.2005.00659.X
T Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, Marvin S Swartz, Sonia M Davis, Robert A Rosenheck, Diana O Perkins, Richard SE Keefe, Clarence E Davis, Joanne Severe, John K Hsiao, Catie Investigators, Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic American Journal of Psychiatry. ,vol. 163, pp. 611- 622 ,(2006) , 10.1176/APPI.AJP.163.4.611